PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection
Eliano Pio Navarese, Przemysław Podhajski, Paul A. Gurbel, Klaudyna Grzelakowska, Eleonora Ruscio, Udaya S. Tantry, Przemysław Magielski, Aldona Kubica, Piotr Niezgoda, Piotr Adamski, Roman Junik, Grzegorz Przybylski, Marta Pilaczyńska-Cemel, Manali Rupji, Giuśeppe Specchia, Jarosław Pinkas, Robert Gajda, Diana A. Gorog, Felicita Andreotti, Jacek Kubica
Topics & Concepts
MedicineClinical endpointPlaceboPCSK9Internal medicineGastroenterologyAdverse effectRandomized controlled trialLipoproteinPathologyCholesterolAlternative medicineLDL receptorLipoproteins and Cardiovascular HealthCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research